Pfizer (NYSE:PFE) has agreed to pay $59.7 million to resolve allegations that Biohaven Pharmaceuticals, acquired by Pfizer in ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

Pfizer will pay $60 million to settle allegations that one of its subsidiaries incentivized healthcare providers to prescribe ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

Pfizer (PFE), on behalf of its wholly-owned subsidiary Biohaven Pharmaceutical (BHVN), has agreed to pay $59,746,277 to resolve allegations ...

Pfizer (PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to induce ...

Oklahoma City Indian Clinic announced it has received a $250,000 charitable contribution from Pfizer to support programs ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.44 which represents a slight increase of $0.43 or 1.65% from the prior close of $26.01. The stock opened at $26.01 and touched a low ...

Wall St., we have followed dividend-paying stocks closely for over 15 years. With a growing audience of savvy baby boomers ...

The Hancock County Commission will be receiving additional funds as part of an antitrust lawsuit filed by the State of West ...